$195 Million is the total value of BOONE CAPITAL MANAGEMENT LLC's 17 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNM | New | UNUM GROUP | $27,552,876 | – | 671,530 | +100.0% | 14.14% | – |
| CI | New | CIGNA CORP NEW | $19,558,669 | – | 59,029 | +100.0% | 10.04% | – |
| LLY | New | LILLY ELI & CO | $17,358,376 | – | 47,448 | +100.0% | 8.91% | – |
| New | ENOVIS CORPORATION | $14,784,686 | – | 276,246 | +100.0% | 7.59% | – | |
| DHR | New | DANAHER CORPORATION | $14,427,170 | – | 54,356 | +100.0% | 7.40% | – |
| OGN | New | ORGANON & CO | $13,916,458 | – | 498,262 | +100.0% | 7.14% | – |
| MOH | New | MOLINA HEALTHCARE INC | $13,025,198 | – | 39,444 | +100.0% | 6.68% | – |
| ABT | New | ABBOTT LABS | $12,308,118 | – | 112,106 | +100.0% | 6.32% | – |
| ABBV | New | ABBVIE INC | $12,261,836 | – | 75,873 | +100.0% | 6.29% | – |
| BIIB | New | BIOGEN INC | $11,587,164 | – | 41,843 | +100.0% | 5.95% | – |
| MDRX | New | VERADIGM INC | $10,584,000 | – | 600,000 | +100.0% | 5.43% | – |
| APEN | New | APOLLO ENDOSURGERY INC | $7,162,637 | – | 718,419 | +100.0% | 3.68% | – |
| QTRX | New | QUANTERIX CORP | $6,789,616 | – | 490,225 | +100.0% | 3.48% | – |
| CPSI | New | COMPUTER PROGRAMS & SYS INC | $6,188,875 | – | 227,365 | +100.0% | 3.18% | – |
| AFMD | New | AFFIMED N V | $3,558,483 | – | 2,869,744 | +100.0% | 1.83% | – |
| CABA | New | CABALETTA BIO INC | $2,468,659 | – | 266,882 | +100.0% | 1.27% | – |
| CSII | New | CARDIOVASCULAR SYS INC DEL | $1,350,518 | – | 99,157 | +100.0% | 0.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNUM GROUP | 4 | Q3 2023 | 15.9% |
| THE CIGNA GROUP | 4 | Q3 2023 | 12.3% |
| MOLINA HEALTHCARE INC | 4 | Q3 2023 | 11.7% |
| DANAHER CORPORATION | 4 | Q3 2023 | 10.4% |
| ENOVIS CORPORATION | 4 | Q3 2023 | 9.8% |
| BIOGEN INC | 4 | Q3 2023 | 7.8% |
| QUANTERIX CORP | 4 | Q3 2023 | 4.9% |
| AMGEN INC | 3 | Q3 2023 | 9.0% |
| BAXTER INTL INC | 3 | Q3 2023 | 11.2% |
| ABBVIE INC | 3 | Q2 2023 | 6.6% |
View BOONE CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View BOONE CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.